Sandra Blanco, Rosa Penin, Irma Casas, Dolores López, Ramón Romero

Slides:

Advertisements

Similar presentations

Parathyroidectomy: Whom and when?

Advertisements

Anemia management in chronic kidney disease

Lipopheresis in the nephrotic syndrome

Epidemiology of diabetic nephropathy in Spain

Obesity, inflammation, and kidney disease

Volume 56, Pages S31-S36 (July 1999)

Parathyroidectomy: Whom and when?

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

Progression of renal failure and hypertensive nephrosclerosis

Haiyan Wang, Luxia Zhang, Jicheng Lv Kidney International

Volume 70, Pages S21-S25 (December 2006)

Volume 57, Pages S32-S37 (April 2000)

A new era in phosphate binder therapy: What are the options?

Volume 70, Issue 11, Pages (December 2006)

Nephrology Crosswords: Hemodialysis

The epidemiology of chronic kidney disease

Volume 87, Issue 2, Pages (February 2015)

The role of protein kinase C activation in diabetic nephropathy

Edmund G. Lowrie Kidney International

Prevention of renal failure: The Malaysian experience

Study of Heart and Renal Protection (SHARP)

Volume 56, Issue 5, Pages (November 1999)

Sunita Dheenan, William L. Henrich Kidney International

Volume 70, Issue 12, Pages (December 2006)

Volume 67, Pages S48-S51 (January 2005)

Volume 76, Issue 5, Pages (September 2009)

New insights in uremic toxins

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 63, Pages S38-S42 (February 2003)

Proteinuria and hypertensive nephrosclerosis in African Americans

Non-immunologic intervention in chronic allograft nephropathy

Microbiology and outcomes of peritonitis in North America

Nephrology in Latin America, with special emphasis on Brazil

Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia

AGEs in foods: Do they play a role in uremia?

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

The global challenge of chronic kidney disease

Nephrology Crossword: Glomerulonephritis

Volume 71, Issue 4, Pages (February 2007)

Volume 60, Issue 1, Pages (July 2001)

A man with a hole in his penis

Proteinuria screening for children

Volume 54, Pages S192-S194 (September 1998)

Peritoneal dialysis in Mexico

Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.

Phosphate binders on iron basis: A new perspective?

Clinical benefits of slowing the progression of renal failure

Organ transplantation goes to the movies

David Z. Levine, M.D., Michelle Iacovitti, Kevin D. Burns, Amy Slater

Atherosclerotic nephropathy

Volume 55, Pages S3-S16 (June 1999)

Early detection and prevention of diabetic nephropathy: A challenge calling for mandatory action for Mexico and the developing world Ricardo Correa-Rotter,

Volume 83, Issue 4, Pages (April 2013)

Volume 72, Issue 11, Pages (December 2007)

Is it the low-protein diet or simply the salt restriction?

Charles A. Herzog Kidney International

Volume 70, Issue 3, Pages (August 2006)

Volume 70, Issue 3, Pages (August 2006)

Volume 71, Issue 9, Pages (May 2007)

Volume 74, Issue 9, Pages (November 2008)

Membranous nephropathy: recent travels and new roads ahead

The International Pediatric Peritonitis Registry: Starting to walk

Evaluation of the Losartan in Hemodialysis (ELHE) Study

Renal vascular disease in the elderly

Volume 55, Pages S41-S46 (June 1999)

Lipoprotein abnormalities in diabetic nephropathy

Volume 54, Pages S112-S119 (December 1998)

Morphology of the heart and arteries in renal failure

Development and differentiation of endothelium

Presentation transcript:

Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy Sandra Blanco, Rosa Penin, Irma Casas, Dolores López, Ramón Romero Kidney International Volume 62, Pages S27-S31 (December 2002) DOI: 10.1046/j.1523-1755.62.s82.6.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Proteinuria, glomerulosclerotic lesions, and glomeruli staining desmin in the three groups at the end of the study. Values are given as mean ± SEM, and significance was determined using ANOVA. P between groups < 0.05. Abbreviations are: QP, prevention with quinapril; DP, prevention with diltiazem (DZM); Q+DT, treatment with quinapril plus DZM; QT, treatment with quinapril; DT, treatment with DZM; FGS lesions, glomerulosclerotic lesions. Kidney International 2002 62, S27-S31DOI: (10.1046/j.1523-1755.62.s82.6.x) Copyright © 2002 International Society of Nephrology Terms and Conditions